EP3397281
BUFFERED FORMULATIONS OF BEVACIZUMAB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.12.2016EP published:
9.9.2020EP application number:
16826865.4
EPO information:
European Patent Register
Max expiry date:
27.12.2036
Title:
BUFFERED FORMULATIONS OF BEVACIZUMAB
Timeline
Today
28.12.2016EP application
9.9.2020EP Publication
Owner
Name:
Outlook Therapeutics, Inc.Address:
7 Clarke Drive, Cranbury, NJ 08512, US
Inventor
Name:
TADDEI, MariaAddress:
Cranbury New Jersey 08512, US
Name:
CHEUNG, JessicaAddress:
Cranbury New Jersey 08512, US
Name:
GUTKA, HitenAddress:
Cranbury New Jersey 08512, US
Priority
Number:
201562272116 PDate:
29.12.2015Country:
US
Classification
Categories:
A61K 39/395, C07K 16/22, C07K 16/24, A61P 35/00